Soligenix, Inc. (SNGX)
1.33
-0.08
(-5.67%)
USD |
NASDAQ |
Dec 30, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Soligenix EPS Diluted (Quarterly): -0.5846 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Insmed, Inc. | -1.747 |
| Tonix Pharmaceuticals Holding Corp. | -3.587 |
| Citius Oncology, Inc. | -0.0617 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.531M |
| Total Expenses (Quarterly) | 2.531M |
| Enterprise Value | 3.274M |
| Earnings Yield | -275.1% |
| Normalized Earnings Yield | -280.20 |